Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;38(6):736-744.
doi: 10.1002/humu.23218. Epub 2017 Apr 13.

Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis

Affiliations

Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis

A Dessa Sadovnick et al. Hum Mutat. 2017 Jun.

Abstract

Genetic variants in the purinergic receptors P2RX4 and P2RX7 have been shown to affect susceptibility to multiple sclerosis (MS). In this study, we set out to evaluate whether rare coding variants of major effect could also be identified in these purinergic receptors. Sequencing analysis of P2RX4 and P2RX7 in 193 MS patients and 100 controls led to the identification of a rare three variant haplotype (P2RX7 rs140915863:C>T [p.T205M], P2RX7 rs201921967:A>G [p.N361S], and P2RX4 rs765866317:G>A [p.G135S]) segregating with disease in a multi-incident family with six family members diagnosed with MS (logarithm of odds = 3.07). Functional analysis of this haplotype in HEK293 cells revealed impaired P2X7 surface expression (P < 0.01), resulting in over 95% inhibition of adenosine triphosphate (ATP)-induced pore function (P < 0.001) and a marked reduction in phagocytic ability (P < 0.05). In addition, transfected cells showed 40% increased peak ATP-induced inward current (P < 0.01), and a greater Ca2+ response to the P2X4 135S variant compared with wild type (P < 0.0001). Our study nominates rare genetic variants in P2RX4 and P2RX7 as major genetic contributors to disease, further supporting a role for these purinergic receptors in MS and the disruption of transmembrane cation channels leading to impairment of phagocytosis as the pathological mechanisms of disease.

Keywords: P2RX4, P2RX7, P2X4, P2X7, variant; familial, Mendelian, multiple sclerosis; mutation.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Pedigree presenting the P2X7 p.T205M, P2X7 p.N361S and P2X4 p.G135S haplotype and protein conservation
A) Males are represented by squares and females by circles with the proband indicated win an arrow head. Patients diagnosed with MS have black filled symbols with corresponding age at onset of disease when available. Heterozygote carriers for all three mutations (M) and wild type (wt) haplotypes are indicated. B) Conservation of P2X7 and P2X4 variants in orthologs and human paralogs are highlighted in black. Protein homologs were aligned via ClustalO, and RefSeq accession numbers are provided.
Figure 2
Figure 2. P2X7 functional assay
A) ATP induced ethidium uptake was used to measure P2X7 pore formation in HEK293 cells transfected with various P2X7 and/or P2X4 constructs. The mean fluorescent intensity of ethidium uptake into cells was measured at 5 sec intervals by two-color flow-cytometry. B) P2X7 expression on the surface of HEK 293 cells transfected with AcGFP-tagged P2X7 and/or P2X4 constructs. Bars represent mean values and SEM of three replicate experiments. WT = wild type. *p<0.05, **p<0.01, ***p<0.001.
Figure 3
Figure 3. P2X4 functional assay using HEK293 cells transfected with AcGFP, wild type P2X4-AcGFP or P2X4-G135S-AcGFP
A) Whole-cell averaged current traces from mock vector control alone (n = 6 cells), P2X4-WT (n = 6 cells) and P2X4-G135S (n = 10 cells) in response to ATP (100 μM). B) Typical Ca2+ influx traces. Ca2+ (3 mM) was added 40 sec prior to the addition of 100 μM ATPγS. Normalized Ca2+ influx from four separated experiments. *p<0.01; **p<0.0001.

Comment in

References

    1. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5’-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006;112:358–404. - PubMed
    1. Buell G, Chessell IP, Michel AD, Collo G, Salazzo M, Herren S, Gretener D, Grahames C, Kaur R, Kosco-Vilbois MH, Humphrey PP. Blockade of human P2X7 receptor function with a monoclonal antibody. Blood. 1998;92:3521–3528. - PubMed
    1. Burnstock G. P2X ion channel receptors and inflammation. Purinergic Signal. 2016;12:59–67. - PMC - PubMed
    1. Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C, Lincoln SJ, Lepretre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet. 2011;89:398–406. - PMC - PubMed
    1. de Rivero Vaccari JP, Dietrich WD, Keane RW. Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metab. 2014;34:369–375. - PMC - PubMed

Publication types